| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 9.47 | -0.19 (-1.97%) | 7.85 - 9.91 | 0.0 |
Market data as of 6:06PM 06/19/13. Quotes are delayed by at least 15 min.
The investment seeks capital growth. The fund invests principally in common stocks (including indirect holdings of common stock through depositary receipts) issued by foreign companies, including countries with developed or emerging markets. It may invest in large, medium, or small companies without regard to market capitalization.
| Total Return | -- |
|---|---|
| Yield (Trailing 12 Mo.) | 0.95% |
| Expense Ratio | 1.52% |
| Front Load | None |
| Deferred Load | None |
| Minimum Investment | $1,000 |
| Management Tenure | 12 Years |
| Fund Inception | 05/01/1939 |
| Timeframe | SLSSX | S&P 500 | Foreign Large Growth |
|---|---|---|---|
| 1 Month | 0.42% | 2.34% | -1.28% |
| 3 Month | 0.52% | 8.22% | 2.53% |
| Year-to-Date | 4.44% | 15.37% | 5.27% |
| 1 Year | 23.54% | 27.28% | 23.55% |
| 3 Year | 4.89% | 16.87% | 10.98% |
| 5 Year | -1.33% | 5.43% | -0.65% |
| 10 Year | 4.29% | 7.58% | 8.84% |
| Since Inception | -- | 10.42% | -- |
| Basic Materials | 9.52% | |
|---|---|---|
| Consumer Cyclical | 14.54% | |
| Financial Services | 9.00% | |
| Real Estate | 4.99% | |
| Consumer Defensive | 15.75% | |
| Healthcare | 13.80% | |
| Utilities | 0.00% | |
| Communication Services | 3.33% | |
| Energy | 0.00% | |
| Industrials | 22.31% | |
| Technology | 6.76% |
| By Percent | Short | 0% | Long | Net | |
|---|---|---|---|---|---|
| Stock | -- | 3.27 | 3.27 | ||
| Bond | -- | 0.00 | 0.00 | ||
| Other | -- | 0.00 | 0.00 | ||
| Foreign Stock | -- | 94.44 | 94.44 | ||
| Foreign Bond | -- | 0.00 | 0.00 | ||
| Total | -- | 97.71 | 97.71 | ||
| Cash | -- | 2.30 | 2.30 | ||
| Total Net Assets | $68.16M |
|---|---|
| Total Stock Holdings | 39 |
| Total Bond Holdings | 0 |
| Company | YTD Return | % of Assets |
|---|---|---|
| HEIOas.SIG | -- | 6.30% |
| Schneider Electric | -- | 5.93% |
| Compagnie Financiere Richemont SA | -- | 5.58% |
| Kühne & Nagel International AG | -- | 4.87% |
| Schindler Holding AG | 3.31% | 4.51% |
| Hang Lung Group Ltd. | -- | 4.34% |
| Essilor International SA | -- | 4.09% |
| TS | 3.10% | 3.62% |
| Brazil Pharma SA | -- | 3.60% |
| NLSN | 12.23% | 3.27% |
| Valuation | SLSSX | Category Range |
|---|---|---|
| Price/Earnings | 10.83 | |
| Price/Book | 1.50 | |
| Price/Sales | 1.22 | |
| Price/Cash Flow | 6.26 | |
| Dividend Yield | 2.07 | |
| LT Earnings | 10.57 | |
| Historical Earnings | 6.45 | |
| Sales Growth | 10.69 | |
| Cash-Flow Growth | 40.91 | |
| Book-Value Growth | 3.48 |
| Management Style | |||
|---|---|---|---|
| Large Cap | |||
| Medium Cap | |||
| Small Cap | |||
 |  |  |
| Rating | vs Category | |
|---|---|---|
| Overall |  | |
| Risk | Avg | |
| Return | Below Avg |
| Pretax Return | 4.89% |
|---|---|
| Tax-adjusted Return | 4.35% |
| Tax Cost Ratio | 0.51% |
| Potential Cap Gains | -8.12% |
